Title:
AMORPHOUS SOLID DISPERSION COMPRISING (S) -1- (1-ACRYLOYLPYRROLIDIN-3-YL) -3- ( (3, 5-DIMETHOXYPHENYL) ETHYNYL) -5- (METHYLAMINO) -1H-PYRAZOLE-4-CARBOXAMIDE
Document Type and Number:
WIPO Patent Application WO/2023/078179
Kind Code:
A1
Abstract:
The present invention provides an amorphous solid dispersion comprises (S) -1- (1-acryloylpyrrolidin-3-yl) -3- ( (3, 5-dimethoxyphenyl) ethynyl) -5- (methylamino) -1H-pyrazole-4-carboxamide (Compound I) and a pharmaceutically acceptable polymer, and a pharmaceutical composition comprising the amorphous solid dispersion. The amorphous solid dispersion of the present invention is stable upon storage and provides better solubility and bioavailability when comparing with a crystalline form.
More Like This:
Inventors:
CHEN XIANGYANG (CN)
Application Number:
PCT/CN2022/128315
Publication Date:
May 11, 2023
Filing Date:
October 28, 2022
Export Citation:
Assignee:
BEIJING INNOCARE PHARMA TECH CO LTD (CN)
International Classes:
A61K31/4155; A61K9/14; A61K9/20; A61K9/48; A61K47/38
Domestic Patent References:
WO2021129565A1 | 2021-07-01 | |||
WO2018049781A1 | 2018-03-22 | |||
WO2020208592A1 | 2020-10-15 | |||
WO2007129066A1 | 2007-11-15 |
Foreign References:
CN113490492A | 2021-10-08 |
Attorney, Agent or Firm:
INTELIGHT IP LAW FIRM (CN)
Download PDF: